590 related articles for article (PubMed ID: 22606290)
1. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
[TBL] [Abstract][Full Text] [Related]
2. Localization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons.
Prieto AL; O'Dell S; Varnum B; Lai C
Neuroscience; 2007 Dec; 150(2):319-34. PubMed ID: 17980494
[TBL] [Abstract][Full Text] [Related]
3. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
[TBL] [Abstract][Full Text] [Related]
4. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
[TBL] [Abstract][Full Text] [Related]
5. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
Elife; 2014 Sep; 3():. PubMed ID: 25265470
[TBL] [Abstract][Full Text] [Related]
6. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.
Al Kafri N; Hafizi S
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510
[TBL] [Abstract][Full Text] [Related]
8. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.
Dantas-Barbosa C; Lesluyes T; Loarer FL; Chibon F; Treilleux I; Coindre JM; Meeus P; Brahmi M; Bally O; Ray-Coquard I; Sunyach MP; Cesne AL; Mir O; Bonvalot S; Toulmonde M; Italiano A; Saintigny P; Jean-Denis M; Ducimetiere F; Ranchere D; El Sayadi H; Alberti L; Blay JY
Br J Cancer; 2017 Dec; 117(12):1787-1797. PubMed ID: 29024938
[TBL] [Abstract][Full Text] [Related]
9. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
[TBL] [Abstract][Full Text] [Related]
10. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.
Zdżalik-Bielecka D; Poświata A; Kozik K; Jastrzębski K; Schink KO; Brewińska-Olchowik M; Piwocka K; Stenmark H; Miączyńska M
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244439
[TBL] [Abstract][Full Text] [Related]
11. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells.
Park HJ; Baen JY; Lee YJ; Choi YH; Kang JL
Mol Biol Cell; 2012 Aug; 23(16):3254-65. PubMed ID: 22740630
[TBL] [Abstract][Full Text] [Related]
12. Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.
el Sayadi H; Pissaloux D; Alberti L; Tabone-Eglinger S; Ranchere D; Decouvelaere AV; Tabone E; Ray-Coquard I; Caux C; Fayette J; Blay JY
Target Oncol; 2013 Dec; 8(4):261-9. PubMed ID: 23354874
[TBL] [Abstract][Full Text] [Related]
13. TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.
Ruicci KM; Meens J; Plantinga P; Stecho W; Pinto N; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Howlett CJ; Boutros PC; Ailles L; Nichols AC
J Exp Clin Cancer Res; 2020 Oct; 39(1):217. PubMed ID: 33059733
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B
Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935
[TBL] [Abstract][Full Text] [Related]
15. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.
Waizenegger JS; Ben-Batalla I; Weinhold N; Meissner T; Wroblewski M; Janning M; Riecken K; Binder M; Atanackovic D; Taipaleenmaeki H; Schewe D; Sawall S; Gensch V; Cubas-Cordova M; Seckinger A; Fiedler W; Hesse E; Kröger N; Fehse B; Hose D; Klein B; Raab MS; Pantel K; Bokemeyer C; Loges S
Leukemia; 2015 Mar; 29(3):696-704. PubMed ID: 25102945
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.
Kimani SG; Kumar S; Bansal N; Singh K; Kholodovych V; Comollo T; Peng Y; Kotenko SV; Sarafianos SG; Bertino JR; Welsh WJ; Birge RB
Sci Rep; 2017 Mar; 7():43908. PubMed ID: 28272423
[TBL] [Abstract][Full Text] [Related]
17. Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization.
Cosemans JM; Van Kruchten R; Olieslagers S; Schurgers LJ; Verheyen FK; Munnix IC; Waltenberger J; Angelillo-Scherrer A; Hoylaerts MF; Carmeliet P; Heemskerk JW
J Thromb Haemost; 2010 Aug; 8(8):1797-808. PubMed ID: 20546121
[TBL] [Abstract][Full Text] [Related]
18. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation.
Chen J; Carey K; Godowski PJ
Oncogene; 1997 May; 14(17):2033-9. PubMed ID: 9160883
[TBL] [Abstract][Full Text] [Related]
19. The Gas6/TAM System and Multiple Sclerosis.
Bellan M; Pirisi M; Sainaghi PP
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801848
[TBL] [Abstract][Full Text] [Related]
20. Expression of the receptor protein-tyrosine kinases Tyro-3, Axl, and mer in the developing rat central nervous system.
Prieto AL; Weber JL; Lai C
J Comp Neurol; 2000 Sep; 425(2):295-314. PubMed ID: 10954847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
